Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

American Oriental Makes Another Acquisition

publication date: Aug 10, 2007
Company Announces Q2 Results American Oriental Bioengineering (NYSE: AOB) will pay $40 million to buy Guangxi Boke Pharmaceutical Co. Ltd. Like American Oriental, Guangxi Boke is engaged in the business of plant-based healthcare. The privately held company produced $12 million in revenue during 2006, while American Oriental is expected to have sales of $158 million in 2007. In June, American Oriental bought Changchun Xinan Pharmaceutical Group for $30 million (see story). More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital